| 标题 |
A chemotherapy-free, pathological response-adapted strategy using trastuzumab–pertuzumab and T-DM1 in HER2-positive early breast cancer: the PHERGain-2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:L. Garrigós; M. Ruiz-Borrego; J.M. Pérez-García; A. Guerrero-Zotano; A. Cortés-Salgado; et al 出版日期:2026 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)